These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 4836755

  • 21. [Progress in the treatment of migraine and migrainoid headaches].
    Kaemmerer E.
    Med Welt; 1966 Dec 17; 51():2812-4. PubMed ID: 5976170
    [No Abstract] [Full Text] [Related]

  • 22. [Plasma and platelet serotonin in children with essential headache].
    Nicoli L, Mambelli M, Scanabissi E, Franzoni E, Guidi M, Gualandi S, Corsini F.
    Boll Soc Ital Biol Sper; 1983 Aug 30; 59(8):1053-8. PubMed ID: 6626340
    [Abstract] [Full Text] [Related]

  • 23. Platelet serotonin (5-HT) and 5-HT releasing factor in plasma of migrainous patients.
    Mück-Seler D, Deanović Z, Dupelj M.
    Headache; 1979 Jan 30; 19(1):14-7. PubMed ID: 759400
    [No Abstract] [Full Text] [Related]

  • 24. Concentration and uptake of 5-hydroxytryptamine in platelets from cluster headache and migraine patients.
    Waldenlind E, Ross SB, Sääf J, Ekbom K, Wetterberg L.
    Cephalalgia; 1985 Mar 30; 5(1):45-54. PubMed ID: 3921257
    [Abstract] [Full Text] [Related]

  • 25. Rational treatment of migraine.
    Weber RB.
    South Med J; 1972 Jun 30; 65(6):737-40. PubMed ID: 5032378
    [No Abstract] [Full Text] [Related]

  • 26. Migrainous neuralgia.
    Eadie MJ, Sutherland JM.
    Med J Aust; 1966 Jun 18; 1(25):1053-7. PubMed ID: 5944387
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Platelet substance P and 5-hydroxytryptamine in migraine and tension-type headache.
    Nakano T, Shimomura T, Takahashi K, Ikawa S.
    Headache; 1993 Jun 18; 33(10):528-32. PubMed ID: 7507472
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Blood platelet 5-hydroxytryptamine accumulation and migraine.
    Carroll JD, Coppen A, Swade CC, Wood KM.
    Ups J Med Sci Suppl; 1980 Jun 18; 31():10-2. PubMed ID: 6935852
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Gangrene induced by methysergide and ergotamine. A case report.
    Vaughan-Lane T.
    J Bone Joint Surg Br; 1979 May 18; 61-B(2):213-4. PubMed ID: 438273
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Current concepts in the pathogenesis and interval treatment of migraine.
    Anthony M, Lance JW.
    Drugs; 1972 May 18; 3(3):153-8. PubMed ID: 4403461
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Vasomotor phenomena, platelet antagonism and migraine therapy.
    Dalessio DJ, Otis S, Smith R.
    Res Clin Stud Headache; 1978 May 18; 6():34-40. PubMed ID: 725254
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.